Free 7-day Trial
All Articles and Columns »

Weekly CEO Buys Highlight: Saul Centers Inc, Harvard Bioscience Inc, BGC Partners Inc., Chatham Lodging Trust, Kaman Corp.

guruyt

guruyt

4 followers
Last week’s top five stocks that were bought by their CEOs were Saul Centers Inc, Harvard Bioscience Inc, BGC PARTNERS, INC, CHATHAM LODGING TRUST, and Kaman Corp. According to [url=http://www.gurufocus.com/InsiderBuy.php]GuruFocus Insider Data[/url], these are the largest CEO buys during the past week.

Saul Centers Inc. (BFS): CEO, 10% Owner B Francis Saul Ii Bought 18,903 Shares

CEO, 10% Owner of Saul Centers Inc. (BFS) B Francis Saul Ii bought 18,903 shares during the past week at an average price of $42.69. SAUL CENTERS, INC. is a real estate investment trust which is engaged in the management and development of the shopping center business of the Saul Organization. Saul Centers Inc. has a market cap of $783.3 million; its shares were traded at around $42.69 with and P/S ratio of 4.9. The dividend yield of Saul Centers Inc. stocks is 3.4%. Saul Centers Inc. had an annual average earning growth of 0.7% over the past 10 years.

BFS recently reported its second quarter results. Total revenue for the three months ended June 30, 2010 increased 1.8% to $40,121,000 compared to $39,416,000 for the three months ended June 30, 2009. Operating income increased 1.4% to $10,717,000 for the 2010 Quarter compared to $10,574,000 for the 2009 Quarter.

Buy: CEO, 10% Owner B Francis Saul Ii bought 1,600 shares of BFS stock on 09/20/2010 at the average price of 43.82. B Francis Saul Ii owns at least 410,342 shares after this. The price of the stock has decreased by 2.58% since. There are mixed trades from other insiders.

Harvard Bioscience Inc. (HBIO): CEO, 10% Owner Chane Graziano Bought 100,000 Shares

CEO, 10% Owner of Harvard Bioscience Inc. (HBIO) Chane Graziano bought 100,000 shares on 09/16/2010 at an average price of $3.72. HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Harvard Bioscience Inc. has a market cap of $105.4 million; its shares were traded at around $3.72 with a P/E ratio of 12.8 and P/S ratio of 1.2. Harvard Bioscience Inc. had an annual average earning growth of 5% over the past 5 years.

HBIO recently reported its second quarter 2010 results. Revenues for the three months ended June 30, 2010 were $25.9 million, an increase of $7.9 million, or 43.5%, compared to revenues of $18.0 million for the three months ended June 30, 2009. Currency exchange rate changes had a negative 3.6% effect on revenues in the second quarter of 2010 compared with the second quarter of 2009, and the Company's Denville Scientific business, which we acquired in September 2009, had a positive 36.1% effect on revenues. Excluding the effects of currency exchange rate changes and the Denville acquisition, the Company's organic revenue growth for the second quarter of 2010 was 11.0% over the same period in the previous year.

Buy: CEO, 10% Owner Chane Graziano bought 100,000 shares of HBIO stock on 09/16/2010 at the average price of 3.58. Chane Graziano owns at least 3,798,481 shares after this. The price of the stock has increased by 3.91% since.

BGC PARTNERS, INC. (BGCP): Chairman and CEO, 10% Owner Howard W Lutnick Bought 50,366 Shares

Chairman and CEO, 10% Owner of BGC PARTNERS, INC. (BGCP) Howard W Lutnick bought 50,366 shares on 09/20/2010 at an average price of $5.72. BGC PARTNERS, INC. is a global full-service inter-dealer broker, specializing in the trading of financial instruments and related derivatives products. Bgc Partners, Inc. has a market cap of $519.6 million; its shares were traded at around $5.72 with a P/E ratio of 12.9 and P/S ratio of 0.4. The dividend yield of Bgc Partners, Inc. stocks is 9.8%.

BGCP recently reported its second quarter 2010 results. The Company’s revenues for the second quarter of 2010 in accordance with U.S. Generally Accepted Accounting Principles (“GAAP”) increased by 14.9 percent to $335.7 million, compared with $292.1 million in the second quarter of 2009.

Buy: Director John H Dalton bought 9,000 shares of BGCP stock on 07/21/2010 at the average price of 4.89. John H Dalton owns at least 49,807 shares after this. The price of the stock has increased by 16.97% since.

CHATHAM LODGING TRUST (CLDT): Chairman, President and CEO Jeffrey H Fisher Bought 7,400 Shares

Chairman, President and CEO of CHATHAM LODGING TRUST (CLDT) Jeffrey H Fisher bought 7,400 shares during the past week at an average price of $17.42. Chatham Lodging Trust is a self-advised hotel REIT, formed to invest in premium-branded upscale extended-stay and select-service hotels. Chatham Lodging Trust has a market cap of $160.3 million; its shares were traded at around $17.42 .

Revenue per available room for the 2010 second quarter at the company's hotels improved 10.2 percent to $81.00, led by a 15.5 percent increase in occupancy to 78.2 percent, partially offset by a 4.6 percent decline in average daily rate to $103.55.

Kaman Corp. (KAMN): Chm, Pres & CEO Neal J Keating Bought 2,000 Shares

Chm, Pres & CEO of Kaman Corp. (KAMN) Neal J Keating bought 2,000 shares on 09/17/2010 at an average price of $26.39. Kaman Corporation is in the following business segments: Aerospace, Industrial Distribution, and Music Distribution. Kaman Corp. has a market cap of $684.8 million; its shares were traded at around $26.39 with a P/E ratio of 26.7 and P/S ratio of 0.6. The dividend yield of Kaman Corp. stocks is 2.2%.

John Keeley owns 1,103,860 shares as of 06/30/2010, which accounts for 0.44% of the $5.56 billion portfolio of Keeley Fund Management. Mario Gabelli owns 3,510,658 shares as of 06/30/2010, which accounts for 0.48% of the $16.22 billion portfolio of GAMCO Investors.

Buy: Senior Vice President / CFO William C Denninger bought 4,200 shares of KAMN stock on 05/25/2010 at the average price of 23.21. William C Denninger owns at least 23,162 shares after this. The price of the stock has increased by 13.7% since.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 4.5/5 (2 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide